יחס מחיר לרווח Cryo-Cell International, Inc. (CCEL)

Cryo-Cell International (CCEL) is a leader in the private biobanking sector, developing regenerative services in collaboration with Duke University; this market valuation shown on GURU.Markets currently stands at -21.40. The company generates its primary revenue from the cryopreservation of client tissues and umbilical cord blood. High costs associated with the transfer of biomaterials provide the firm with pricing power, allowing it to regularly increase storage cell rental rates.

Stable storage payments for biomaterials at Cryo-Cell International (CCEL) make the P/E ratio dynamics on GURU.Markets an indicator of the business's real value relative to its cash flow. The ratio of market capitalization to net income shows how many years an investor is willing to wait for a return on investment, allowing for a distinction between a fair valuation and a dangerous overpricing amid stagnant operational metrics.